Thotsaporn Morasert

Dr. Thotsaporn Morasert

orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

1 October 2018 in The International Journal of Tuberculosis and Lung Disease
Verified
Journal Article
Closed access
TMThotsaporn Morasert
Thotsaporn Morasert
WWW. Worapas
W. Worapas
RKR. Kaewmahit
R. Kaewmahit
WUW. Uphala
W. Uphala
SETTING: A prison in Suratthani Province, South Thailand. OBJECTIVES: To measure the prevalence of and identify the risk factors associated with tuberculosis (TB) disease among prison inmates. METHOD: This was a cross-sectional surveillance study. All prison inmates were screened for TB using a national TB screening questionnaire and chest X-ray (CXR) in July–December 2015. We collected sputum smear and Xpert® MTB/RIF results from prison inmates with a questionnaire score of 3 points or CXR suggestive of TB. Case definitions were: 1) definite TB: TB confirmed using sputum smear microscopy or Xpert; 2) probable TB: CXR consistent with active TB, together with clinical and CXR improvement after treatment; 3) TB case: definite and probable cases. RESULTS: Of 4007 prison inmates, 84 were diagnosed with TB. TB prevalence was 2.1%: 61 (1.6%) were definite TB cases. TB was associated with human immunodeficiency virus (HIV) positivity (adjusted OR [aOR] 7.22, 95%CI 1.85–28.22, P = 0.004), pre-incarceration income <Thai baht 15 000 (aOR 4.63, 95%CI 1.37–15.69, P = 0.014), overcrowding (aOR 3.73, 95%CI 1.08–12.93, P = 0.038) and prolonged incarceration 3 years (aOR 3.29, 95%CI 1.39–7.82, P = 0.007). CONCLUSIONS: Prevalence of TB disease in Suratthani Central Prison was high. HIV infection, prolonged incarceration, overcrowding and low pre-incarceration income were significant risk factors associated with TB.

27 May 2020 in BMJ Open Respiratory Research
Verified
Journal Article
Open access
PDF file
TMThotsaporn Morasert
Thotsaporn Morasert
MJMethus Jantarapootirat
Methus Jantarapootirat
PPPhichayut Phinyo
Phichayut Phinyo
JPJayanton Patumanond
Jayanton Patumanond
Background: Acute exacerbation of chronic obstructive pulmonary disease (AECOPD) is a common and deteriorating event leading to in-hospital morbidity and mortality. Identification of predictors for in-hospital mortality of AECOPD patients could aid clinicians in identifying patients with a higher risk of death during their hospitalisation. Objective: To explore potential prognostic indicators associated with in-hospital mortality of AECOPD patients. Setting: General medical ward and medical intensive care unit of a university-affiliated tertiary care centre. Methods: A prognostic factor research was conducted with a retrospective cohort design. All admission records of AECOPD patients between October 2015 and September 2016 were retrieved. Stratified Cox’s regression was used for the primary analysis. Results: A total of 516 admission records of 358 AECOPD patients were included in this study. The in-hospital mortality rate of the cohort was 1.9 per 100 person-day. From stratified Cox’s proportional hazard regression, the predictors of in-hospital mortality were aged 80 years or more (HR=2.16, 95% CI: 1.26 to 3.72, p=0.005), respiratory failure on admission (HR=2.50, 95% CI: 1.12 to 5.57, p=0.025), body temperature more than 38°C (HR=2.97, 95% CI: 1.61 to 5.51, p=0.001), mean arterial pressure lower than 65 mm Hg (HR=4.01, 95% CI: 1.88 to 8.60, p<0.001), white blood cell count more than 15 x 109/L (HR=3.51, 95% CI: 1.90 to 6.48, p<0.001) and serum creatinine more than 1.5 mg/dL (HR=2.08, 95% CI: 1.17 to 3.70, p=0.013). Conclusion: Six independent prognostic indicators for in-hospital mortality of AECOPD patients were identified. All of the parameters were readily available in routine practice and can be used as an aid for risk stratification of AECOPD patients.

6 November 2024 in The American Journal of Tropical Medicine and Hygiene
Verified
Journal Article
Closed access
PDF file
ARAtchara Rodgerd
Atchara Rodgerd
TMThotsaporn Morasert
Thotsaporn Morasert
: The global incidence of tuberculosis (TB) in prison is 5 to 70 times greater than that in the general population. The systematic screening and treatment of TB in prison benefit TB control and treatment outcomes. However, no study has supported this in Thailand. Here, we evaluated the effectiveness of long-term, continuous, systematic screening for TB control. We conducted a retrospective study in Suratthani Central Prison, Thailand, using annual TB screening from 2016 to 2020. A positive TB screening was defined as having any TB symptoms or chest radiography abnormality. We collected sputum smear and Xpert® Mycobacterium tuberculosis/rifampicin (MTB/RIF) results from those inmates with positive screening results. Bacteriologically confirmed TB was defined as a positive sputum smear or M. tuberculosis detected by Xpert assay. Inmates with clinically diagnosed TB were also eligible for this study. Those inmates diagnosed with active TB were sent to an isolation zone in prison and received anti-TB medicine using directly observed therapy and were monitored by pulmonologists during the treatment course via telemedicine. Of 18,965 TB screening events, 175 patients were diagnosed with TB. The 5-year prevalence was 922 per 100,000 inmates. The relative reduction in TB prevalence was 60.5% from 2016 to 2020. Overall, 94.3% of TB patients were successfully treated (sum of patients cured and treatment completed). Three TB patients died during the 5-year study period. All occurred in 2016. The systematic screening and treatment of TB in inmates effectively reduced the prevalence and mortality in Suratthani Central Prison. The success rate of treatment in this prison has been consistently high.

1 January 2014 in Japanese Journal of Infectious Diseases
Verified
Journal Article
Open access
PDF file
SKSasisopin Kiertiburanakul
Sasisopin Kiertiburanakul
TMThotsaporn Morasert
Thotsaporn Morasert
SSSayomporn Sirinavin
Sayomporn Sirinavin
WCWasun Chantratita
Wasun Chantratita
Clinical presentations of patients with 2009 H1N1 influenza are generally similar to those of patients with seasonal influenza. A cross-sectional study was conducted among adults at an outpatient clinic in a university hospital setting during the 2009 epidemic. Infections in all patients were confirmed by real-time reverse transcription-polymerase chain reaction. There were 269 patients with 2009 H1N1 influenza and 128 patients with seasonal influenza. Compared with patients with seasonal influenza, patients with 2009 H1N1 influenza were more likely to be aged <20 years (25.7% vs. 8.6%, P < 0.001) and to be students (38.7% vs. 22.0%, P = 0.001), or healthcare workers (20.1% vs. 10.9%, P = 0.022); however, they were less likely to have an underlying disease (25.6% vs. 39.8%, P = 0.004) and influenza vaccination (4.2% vs. 12.2%, P = 0.021). There were no differences in the illness duration, vital signs, and symptoms between groups. Patients with seasonal influenza were more likely to be admitted to the intensive care unit (2.4% vs. 0%, P = 0.033) and exhibited a higher mortality rate (2.4% vs. 0%, P = 0.093). A history of contact with a confirmed 2009 H1N1 influenza case (odds ratio [OR] = 12.91, P < 0.001) and age (OR = 1.05 per 10 years younger, P = 0.015) were associated with 2009 H1N1 influenza infections. In conclusion, these results showed differences in characteristics between the patients with 2009 H1N1 influenza and those with seasonal influenza.

13 September 2022 in International Journal of Chronic Obstructive Pulmonary Disease
Verified
Journal Article
Open access
PDF file
TMThotsaporn Morasert
Thotsaporn Morasert
OKOrakarn Kriengwattanakul
Orakarn Kriengwattanakul
PKPrapasri Kulalert
Prapasri Kulalert
Objective: This study aimed to assess whether the short-term use of macrolide antibiotics during hospitalization can reduce in-hospital all-cause mortality compared to non-macrolide treatment in patients with acute exacerbation of chronic obstructive pulmonary disease (AECOPD). Methods: A propensity score (PS) matching analysis was performed using retrospective data from the admission records of AECOPD patients in the medical general ward and medical intensive care unit of a tertiary care center between October 2015 and September 2018. The multivariable Cox proportional hazard model was performed to eliminate residual confounding after the PS analysis. Results: The mortality rate was 11.1% of 1528 admissions in the PS matching cohort. Approximately 70% of patients had respiratory failure requiring intubation on initial admission, and 34% had pneumonia. Macrolide treatment significantly reduced in-hospital mortality among AECOPD patients (adjusted hazard ratio, 0.55; 95% confidence interval 0.32– 0.96; P=0.034). Clarithromycin was the most commonly prescribed macrolide (80%). Conclusion: Macrolide antibiotics reduced in-hospital mortality in hospitalized AECOPD patients. The combination of antimicrobial and immunomodulatory effects of macrolide treatment could play an essential role.